Company: RNAC
Filing Date: 2025-04-28
Form Type: DEF 14A
Source: 0001453687-25-000075
Chunk: 78

Company: Cartesian Therapeutics, Inc.
Filing Date: 2025-04-28
Form: DEF 14A
Chunk 78
---
 a director has served on our Board for at least six months as of the first business day in January of each year, the director of the Board received an option to purchase 3,800 shares of our Common Stock and 2,600 RSUs on that date, which awards vest in a single installment on the first anniversary of the date of grant, subject to accelerated vesting upon a change in control. If such non-employee director served as the Chairman of the Board as of the first business day in January of each year, that non-employee director received an option to purchase 4,000 shares of our Common Stock that date, subject to the same vesting terms.

Annual Retainer Fees . In addition to option grants, each director received an annual retainer for service on our Board and additional fees for service on a committee of our Board as follows:

• annual director fee of $40,000;

• chairman of the board, $30,000 and lead independent director, $25,000;

• chairman of the Audit Committee, $15,000;

• Audit Committee member other than the chairman, $7,500;

• chairman of the Compensation Committee, $12,000;

• Compensation Committee member other than the chairman, $6,000;

• chairman of the Nominating and Corporate Governance Committee, $10,000;

• Nominating and Corporate Governance Committee member other than the chairman, $5,000;

• chairman of the now-disbanded Research and Development Committee, $12,000; and

• member of the now-disbanded Research and Development Committee other than the chairman, $6,000.

Director fees are paid in arrears in four equal quarterly installments not later than the fifteenth day following the final day of each calendar quarter, provided that the amount of each payment is prorated for any portion of a quarter that a director is not serving on our Board. Each member of our Board is entitled to be reimbursed for reasonable travel and other expenses incurred in connection with attending meetings of the Board and any committee of the Board on which he or she serves.

On March 20, 2024, the Board approved the following amendment to our non-employee director compensation program:

• Following the disbanding of the Research & Development Committee and the formation of the Science and Technology Committee, an annual retainer in the amount of $12,000 was established for the chairman of the Science and Technology Committee, and in the amount of $6,000 for each member